Torrent Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/07/2025 ,inter alia, to consider and approve the Audited Financial Results on Standalone basis and Unaudited Financial Results with limited review on Consolidated basis of the Company for the quarter ended on 30-Jun-25. In the above meeting, the Board would also consider the Issue of Unsecured or Secured Redeemable Non Convertible Debentures or Bonds by way of private placement.